Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 2388-2391, 2005; 10.1373/clinchem.2005.056820
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Käller, M.
Right arrow Articles by Lundeberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Käller, M.
Right arrow Articles by Lundeberg, J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2005;51:2388-2391.)
© 2005 American Association for Clinical Chemistry, Inc.


Technical Briefs

Detection of MC1R Polymorphisms with Protease-Mediated Allele-Specific Extension as an Alternative to Direct Sequencing

Max Käller1, Rainer Tuominen2, Afshin Ahmadian1, Veronica Magnusson2, Suzanne Egyhazi2, Johan Hansson2 and Joakim Lundeberg1,a

1 Department of Biotechnology, The Royal Institute of Technology (KTH), AlbaNova University Center, Stockholm, Sweden;2 Department of Oncology-Pathology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden

aaddress correspondence to this author at: Department of Biotechnology, The Royal Institute of Technology (KTH), AlbaNova University Center, Roslagstullsbacken 21, SE-106 91 Stockholm, Sweden; fax 46-8-5537-8481, e-mail joakim.lundeberg@biotech.kth.se

The first 300 words of the full text of this article appear below.

The red hair color phenotype is associated with an increased risk of developing cutaneous malignant melanoma (1) and has been linked to certain variants of the gene for melanocortin-1 receptor (MC1R) (2)(3)(4). The function of the receptor is to mediate melanin production via binding of its ligand, {alpha}-melanocyte-stimulating hormone, and/or adrenocorticotropic hormone (5). The presence of some MC1R variants fails to shift the production from red/yellow pigment (pheomelanin) to black/brown pigment (eumelanin), causing less efficient protection against ultraviolet radiation. The MC1R gene is highly polymorphic, and many identified variants have been associated with an increased risk of developing malignant melanoma (6)(7). Some of these variants have also been proposed to synergize with mutations of the cyclin-dependent kinase inhibitor 2A gene (CDKN2A) to enhance the melanoma risk further (8)(9).

There are many novel technologies for the analysis of single-nucleotide polymorphisms (SNPs) and mutations. We have previously described an approach to increase the specificity of the allele-specific extension (ASE) technology for SNP genotyping and mutation detection (10). Interestingly, this allows typing of several SNPs that were not possible to analyze by unmodified ASE. The ASE technology uses the ability of DNA polymerases to distinguish matched and mismatched 3' termini of primers and thus to extend only completely matched primers. However, several reports have shown that some 3'-termini mismatches can be elongated and give false-positive results (11). This problem can be circumvented by exploiting the fact that the mismatched primers have slower reaction kinetics. The elongation can be terminated by protease (proteinase K) degradation of the polymerase before any incorrect insertions are made (10). Protease-mediated allele-specific extension (PrASE) is a flexible assay and can be performed at lower temperatures . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.